| Name | Rongliflozin |
|---|
| Description | Rongliflozin (DJT1116PG) is a selective and orally active inhibitor of sodium-glucose co-transporter-2 (SGLT-2). Rongliflozin can be used for the research of type 2 diabetes mellitus (T2DM)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C23H27ClO7.C5H7NO3.5/4H2O |
|---|---|
| Molecular Weight | 602.55 |